Clinical Trials for Bladder Cancer

Evaluating Length of Treatment With PD-1/PD-L1 Inhibitor in Advanced Solid Tumors

NCT ID: NCT04157985

This clinical trial is studying the best length of treatment with a type of cancer therapy called PD-1/PD-L1 inhibitors, which are used for various advanced solid tumors, including lung, bladder, a...

PROGRESS: Precision Oncology Using Genomic Reflexive Evaluations for Study Selection and Survival

NCT ID: NCT06896162

The PROGRESS clinical trial is exploring how a specialized approach to cancer treatment, known as precision medicine, can help patients with advanced solid tumors, including breast, lung, colorecta...

A Dose Escalation and Dose Expansion Study of Intratumoral ONM-501 Alone and in Combination With Cemiplimab in Patients With Advanced Solid Tumors and Lymphomas.

NCT ID: NCT06022029

This clinical trial is studying a new treatment called ONM-501, which can be given alone or combined with another medication called cemiplimab, for patients with advanced solid tumors and lymphomas...

A Home-Based Prehabilitation Exercise Intervention for Improving Physical Function in Patients With Bladder Cancer and Upper Tract Urothelial Cancer, Get Moving Trial

NCT ID: NCT06040762

The "Get Moving Trial" is studying a special exercise program designed to help patients with bladder cancer and upper tract urothelial cancer get stronger before their surgeries. This program, call...

A Bladder-Sparing Treatment Strategies of Large-Volume Non-Muscle-Invasive Bladder Cancer

NCT ID: NCT06735287

This clinical trial is investigating new treatment options for patients with large non-muscle-invasive bladder cancer (NMIBC), specifically tumors that are 5 cm or larger. The goal is to find a way...

Naptumomab Estafenatox in Combination with Durvalumab in Subjects with Selected Advanced or Metastatic Solid Tumor, Including a Cohort Expansion in Esophageal Cancer.

NCT ID: NCT03983954

This clinical trial is investigating a new treatment approach for patients with advanced or metastatic solid tumors, including types of cancer such as breast, ovarian, pancreatic, and esophageal ca...

The Efficacy of Gallium[68Ga]NOTA-DNA Multivalent SGC8 Injection for Bladder Tumour Imaging

NCT ID: NCT06763354

This clinical trial is studying a new imaging method for bladder tumors using a special injection called gallium [68Ga] NOTA-DNA multivalent SGC8. The goal is to see how well this injection can hel...

Radiation Combined With BIspecific T-Cell Engager in DLL3 Expressing Tumors

NCT ID: NCT06814496

This clinical trial is investigating a new treatment approach for patients with certain types of cancer, including melanoma, thyroid cancer, and various other tumors. The main goal is to see if com...

Analysis of Urinary Methylation Patterns Via Liquid Biopsy as an Early Diagnosis Tool

NCT ID: NCT06878027

This clinical trial is investigating how urine tests can help detect bladder cancer early. The researchers are looking at specific changes in the DNA found in urine, known as methylation patterns, ...

Guiding Instillation in Non Muscle-invasive Bladder Cancer Based on Drug Screens in Patient Derived Organoids

NCT ID: NCT05024734

This clinical trial is studying a new way to treat patients with non-muscle invasive bladder cancer, specifically for those at intermediate risk. Researchers will collect tumor samples from patient...

The Use of Remote Monitoring to Improve Patient-Reported Outcomes and Readmission Rates Following Radical Cystectomy

NCT ID: NCT06397040

Intravesical Gemcitabine and Docetaxel for Low Grade Intermediate Risk Bladder Cancer

NCT ID: NCT06488222

This clinical trial is studying a new treatment approach for patients with low-grade intermediate risk bladder cancer, specifically looking at the effectiveness of two medications, gemcitabine and ...

Bladder Fiducial Markers and Multiparametric-MRI (mp-MRI) to Optimize Bladder Chemo-radiotherapy

NCT ID: NCT04442724

This clinical trial is investigating a new way to improve treatment for bladder cancer. Researchers want to see if placing tiny gold markers around the tumor can help doctors accurately find the tu...

A Study of MGC026 in Participants With Advanced Solid Tumors

NCT ID: NCT06242470

This clinical trial is investigating a new treatment called MGC026 for adults with advanced solid tumors, which are types of cancer that have spread or cannot be removed through surgery. The study ...

Telehealth Intervention for Ostomy Self-Management

NCT ID: NCT06528990

This clinical trial, called the Telehealth Intervention for Ostomy Self-Management, is exploring a new way to help patients with colorectal and bladder cancer manage their care after undergoing ost...

Ex VIvo DEtermiNed Cancer Therapy

NCT ID: NCT05231655

The EVIDENT clinical trial is exploring a new way to predict how well patients with solid cancers, such as bladder, kidney, melanoma, sarcoma, glioblastoma, and head and neck cancer, will respond t...

Evaluation of VISIOCYT Bladder Cytology in Real Life

NCT ID: NCT06072027

This clinical trial is studying a new test called VISIOCYT bladder cytology to see how well it works in diagnosing and monitoring bladder cancer in real-life situations. It will include patients wh...

A Clinical Trail to Determine the Safety and Efficacy of the Combination of Tislelizumab With Cisplatin and Gemcitabine, With or Without Trilaciclib for Patients With Untreated Unresectable and Metastatic Urothelial Carcinoma.

NCT ID: NCT06364904

This clinical trial is investigating the safety and effectiveness of a new treatment for patients with bladder cancer that has not been surgically removed and has spread to other parts of the body....

INSPIRE: a Multi-Cancer Early Detection Study

NCT ID: NCT06440018

The INSPIRE trial is a research study focused on finding a better way to detect multiple types of cancer early, including lung, breast, and colorectal cancers, among others. The study aims to devel...

A Novel Multiplex ELISA Assay for Surveilling Patients with History of Bladder Cancer

NCT ID: NCT03193515

This clinical trial is testing a new urine test called a multiplex ELISA assay to help monitor patients who have a history of bladder cancer. The current standard test, known as voided urinary cyto...